Biosafety for Viral Gene Therapies
Join Erich Bozenhardt as he presents his poster, "Biosafety for Viral Gene Therapies," at the ISPE 2020 Biopharmaceutical Manufacturing Virtual Conference throughout both days.
With a maturing pipeline of Gene Therapies, companies are developing commercial manufacturing spaces at a rapid rate.
The novel processes/organisms are challenging companies to develop a look at their Biosafety operational practices, how those practices and GMP compliance influence the design of facilities. This poster will help build an understanding of how to classify vectors/cell lines, how risk groups translate into facility design, and what GMP practices around containment need to be considered for viral gene therapies.
The ISPE 2020 Biopharmaceutical Manufacturing Virtual Conference will focus on innovation in facilities, production methods, and technologies that enable a competitive and sustainable biopharmaceutical product supply for the future. This conference will bring together experts that are developing, implementing, and operating advanced supply chains providing high-quality medicines to global markets.
Read more and register here: https://ispe.org/conferences/2020-ispe-biopharmaceutical-manufacturing-virtual-conference/agenda
Related Happenings At IPS
Event - Speaking
Building Flexibility for Multiple Cell Therapy Processes
June 01, 2020Join Daniel Swanson as he presents Building Flexibility for Multiple Cell Therapy Processes at the ISPE 2020 Biopharmaceutical Manufacturing Virtual Conference. Many cell therapy firms have a diverse pipeline of promising drug
Event - Speaking
Radical Schedule Reduction Strategies for Today's Biopharma Environment
June 02, 2020Join Tom Chapman as he presents on Radical Schedule Reduction Strategies for Today's Biopharmaceutical Environment at the 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference. This live presentation, taking place at t